Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
The elimination of Pfizer's danuglipron removes the nearest competitor and gives Eli Lilly a multi-year head start in the oral small-molecule GLP-1 market
This is an updated version of an article originally published December 2019.
"In addition to significant weight loss, Wegovy is the only GLP-1 for adults with obesity that is proven to reduce the risk of events such as stroke, heart attack, or cardiovascular death in those who also have known heart disease
But many of these studies have only been performed on animals
US$ 27.14
US$ 27.96
US$ 29.06
US$ 27.04
US$ 26.70
US$ 25.05
US$ 24.21
US$ 25.66
US$ 22.11
US$ 29.02
US$ 24.52
US$ 27.63
US$ 28.64
